Physician profile
David Othman
NPI 1760741938
$4,917.40
in general payments reported to CMS, 2019-2025
24 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,117 · 2020: $284 · 2021: $806 · 2022: $542 · 2023: $631 · 2024: $297 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161 · Travel and Lodging: $8.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,161.00 |
| Travel and Lodging | $8.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $961.54 | 2019-2025 | Taltz, Olumiant |
| Galderma Laboratories, L.P. | $923.83 | 2019-2025 | Nemluvio |
| Abbvie INC. | $764.67 | 2019-2024 | |
| Regeneron Healthcare Solutions, INC. | $415.58 | 2022-2025 | Dupixent |
| Genzyme Corporation | $254.10 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $246.41 | 2019-2020 | |
| Janssen Biotech, INC. | $193.67 | 2020-2023 | Tremfya |
| Ucb, INC. | $176.97 | 2019-2021 | |
| Almirall LLC | $149.51 | 2019 | |
| Celgene Corporation | $142.68 | 2019 | |
| Vyne Pharmaceuticals INC. | $141.30 | 2021 | |
| Mayne Pharma Commercial LLC | $130.52 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $117.50 | 2019-2020 | |
| Leo Pharma INC. | $88.43 | 2019-2025 | Adbry |
| Aclaris Therapeutics, INC. | $51.55 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $34.75 | 2023-2025 | Otezla |
| Sun Pharmaceutical Industries INC. | $30.71 | 2019-2020 | |
| Mission Pharmacal Company | $26.75 | 2019 | |
| Epi Health, LLC | $25.90 | 2019-2020 | |
| Journey Medical Corporation | $21.12 | 2024 | |
| Pfizer INC. | $19.91 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Othman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.